Lisa Giulino-Roth

Weill Cornell Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (3)

Year:

2026

The rarity of malignant Hodgkin and Reed Sternberg (HRS) cells in classic Hodgkin lymphoma (cHL) limits the ability to study the genomics of cHL. To circumvent this, our group has previously optimized fluorescence-activated cell sorting to purify HRS cells. Using this approach, we now report the whole-genome sequencing landscape of HRS cells and reconstruct the chronology and likely etiology of pathogenic events leading to cHL. We identified alterations in driver genes not previously described in cHL, APOBEC mutational activity, and the presence of complex structural variants including chromothripsis. We found that high ploidy in cHL is often acquired through multiple, independent chromosomal gains events including whole-genome duplication. Evolutionary timing analyses revealed that structural variants enriched for RAG motifs, driver mutations in B2M, BCL7A, GNA13 , and PTPN1 , and the onset of AID-driven mutagenesis usually preceded large chromosomal gains. This study provides a temporal reconstruction of cHL pathogenesis. Significance: Previous studies in cHL were limited to coding sequences and therefore not able to comprehensively decipher the tumor complexity. Here, leveraging cHL whole-genome characterization, we identify driver events and reconstruct the tumor evolution, finding that structural variants, driver mutations, and AID mutagenesis precede chromosomal gains. This article is highlighted in the In This Issue feature, p. 171

Year:

2025

The rarity of malignant Hodgkin and Reed Sternberg (HRS) cells in classic Hodgkin lymphoma (cHL) limits the ability to study the genomics of cHL. To circumvent this, our group has previously optimized fluorescence-activated cell sorting to purify HRS cells. Using this approach, we now report the whole-genome sequencing landscape of HRS cells and reconstruct the chronology and likely etiology of pathogenic events leading to cHL. We identified alterations in driver genes not previously described in cHL, APOBEC mutational activity, and the presence of complex structural variants including chromothripsis. We found that high ploidy in cHL is often acquired through multiple, independent chromosomal gains events including whole-genome duplication. Evolutionary timing analyses revealed that structural variants enriched for RAG motifs, driver mutations in B2M, BCL7A, GNA13, and PTPN1, and the onset of AID-driven mutagenesis usually preceded large chromosomal gains. This study provides a temporal reconstruction of cHL pathogenesis. Significance: Previous studies in cHL were limited to coding sequences and therefore not able to comprehensively decipher the tumor complexity. Here, leveraging cHL whole-genome characterization, we identify driver events and reconstruct the tumor evolution, finding that structural variants, driver mutations, and AID mutagenesis precede chromosomal gains. This article is highlighted in the In This Issue feature, p. 171

Year:

2023

Collaborators (22)

Raymond K H Yip

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA
View details

Andriy Derkach

Associate Attending Biostatistician

Memorial Sloan Kettering Cancer Center

UNITED STATES
View details

Olivier Elemento

Professor

Weill Cornell Medical College

UNITED STATES
View details

Ola Landgren

Professor of Medicine

Sylvester Comprehensive Cancer Center, University of Miami

UNITED STATES
View details

Siavash Foroughi

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA
View details

james vince

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA
View details

Alexandra Kovach

Director, Hematopathology; Associate Professor, Keck School of Medicine of University of Southern California

Children's Hospital of Los Angeles

UNITED STATES
View details

Britt Christensen

-

AUSTRALIA
View details

Kelly L. Rogers

Laboratory Head, Dynamic Imaging & Centre Manager

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA
View details

Bachisio Ziccheddu

Sylvester Comprehensive Cancer Center, University of Miami

UNITED STATES
View details

Matthew Barth

Clinical Associate Professor

University at Buffalo State University of New York School of Medicine and Biomedical Sciences

UNITED STATES
View details

Henning Walczak

Alexander-von-Humboldt Professor of Biochemistry

University of Cologne

GERMANY
View details

Kate Lawlor

Group Leader

MONASH UNIVERSITY

AUSTRALIA
View details

Edwin Hawkins

Lab Head

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA
View details

Rory Bowden

Lab Head

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA
View details

Oliver Sieber

Laboratory Head

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA
View details

Terzah Horton

Associate Professor

Baylor College of Medicine

UNITED STATES
View details

Craig H. Moskowitz

University of Miami Miller School of Medicine

UNITED STATES
View details

Pradeep Rajasekhar

MONASH UNIVERSITY

AUSTRALIA
View details

James Murphy

Laboratory Head

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA
View details

Jinjin Chen

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA
View details

Francesco Maura

Assistant Professor

Sylvester Comprehensive Cancer Center

UNITED STATES
View details